| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $-1.63598 (Miss by $-1.82598) |
| EPS GAAP Actual | $-1.63598 (Miss by $-1.82598) |
| Revenue Actual | $0.047586B |
| Revenue Surprise | Beat by $47.586M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.48 |
| EPS GAAP Estimate | $0.48 |
| Revenue Estimate | $0.0409B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2028 | 0.92 | 10.79 | 0.91488 | 0.92936 | 1 |
| Jan 2027 | 1.4 | 7.09 | 1.39828 | 1.40172 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -1.64 | -2.17 | 0.047586B | 3.84% | 5.79M |
| FQ3 2025 (Jul 2025) | 0.08 | -0.45 | 52.496B | 99.93% | 52454.2M |
| FQ2 2025 (Apr 2025) | -0.41 | -0.8 | 0.046746B | 22.33% | 10.45M |
| FQ1 2025 (Jan 2025) | 0 | -0.395 | 46.628B | 99.93% | 46591.9M |
| FQ4 2024 (Oct 2024) | 0.0116 | -0.3084 | 0.045761B | 30.78% | 13.76M |
| FQ3 2024 (Jul 2024) | -0.19 | -1.53259 | 0.038512B | 14.13% | -27.63M |
| FQ2 2024 (Apr 2024) | 0.22 | 0.22 | 0.036309B | -78943.76% | 36.31M |
| FQ1 2024 (Jan 2024) | -0.13 | -0.13 | 0.031239B | 100% | 31.24M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.48
Consensus Revenue Estimates
0.0409B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.51 | -- | 0.49438 | 0.52475 | 1 |
| FQ4 2026 (Oct 2026) | 0.55 | 398.18 | 0.53316 | 0.56591 | 1 |
| FQ3 2026 (Jul 2026) | 0.41 | 80.49 | 0.39745 | 0.42186 | 1 |
| FQ2 2026 (Apr 2026) | 0.315 | 230.16 | 0.30605 | 0.32553 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.06B | -- | 0.06B | 0.06B | 2 |
| FQ4 2026 (Oct 2026) | 0.06B | 22.41 | 0.06B | 0.06B | 2 |
| FQ3 2026 (Jul 2026) | 0.06B | -91815.49 | 0.06B | 0.06B | 2 |
| FQ2 2026 (Apr 2026) | 0.05B | 11.38 | 0.05B | 0.05B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.53 | -1.64 | -2.17 | 132.32% |
| FQ3 2025 (Jul 2025) | 0.53 | 0.08 | -0.45 | -562.5% |
| FQ2 2025 (Apr 2025) | 0.39 | -0.41 | -0.8 | 195.12% |
| FQ1 2025 (Jan 2025) | 0.395 | 0 | -0.395 | -INF% |
| FQ4 2024 (Oct 2024) | 0.32 | 0.0116 | -0.3084 | -2658.62% |
| FQ3 2024 (Jul 2024) | 1.34259 | -0.19 | -1.53259 | 806.63% |
| FQ2 2024 (Apr 2024) | 0.22 | 0.22 | 100% | |
| FQ1 2024 (Jan 2024) | -0.13 | -0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.04B | $0.05B | $5.79M | 12.16% |
| FQ3 2025 (Jul 2025) | $0.04B | $52.5B | $52454.2M | 99.92% |
| FQ2 2025 (Apr 2025) | $0.04B | $0.05B | $10.45M | 22.35% |
| FQ1 2025 (Jan 2025) | $0.04B | $46.63B | $46591.9M | 99.92% |
| FQ4 2024 (Oct 2024) | $0.03B | $0.05B | $13.76M | 30.07% |
| FQ3 2024 (Jul 2024) | $0.07B | $0.04B | $-27.63M | -71.74% |
| FQ2 2024 (Apr 2024) | $0B | $0.04B | $36.31M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.03B | $31.24M | 100% |